Skip to content

XOMA Corporation XOMA Net gains (losses) on investments

Net gains (losses) on investments at other companies

Ligand Pharmaceuticals logo
Ligand PharmaceuticalsLGND
-$732K-3,227%
Innoviva, Inc. logo
Innoviva, Inc.INVA
$157.65M+1,264%
ALN
Alnylam PharmaceuticalsALNY
$0+100%
Roivant Sciences logo
Roivant SciencesROIV
$21.59M+201%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
-$18.28M-17.5%
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$22.58M+1,144%

Other financials

Income statement

See full
Revenue$12.3M-22.6%
Operating income-$480.0K-108%
Net income$4.5M+88.6%
EPS (diluted)$0.17+183%

Balance sheet

See full
Cash & equivalents$85.6M-5.2%
Total debt$124.7M+9.0%
Total equity$92.9M+9.7%
Total assets$271.9M+27.8%

Cash flow

See full
Operating cash flow$6.1M+178%
CapEx$3.0K-29.4%
Free cash flow-$2.9M+36.0%

Valuation

See full
Market cap$746.04M+159%
Enterprise value$785.17M+152%
P/E22.1×
P/S15.4×+8.7×

Profitability

See full
Operating margin10.2%+5.5pp
Net margin69.6%+64.0pp
FCF margin-320%-118pp

Returns & leverage

See full
Return on equity38.1%+35.2pp
Debt / equity1.3×0.0×
Current ratio3.6×-2.0×

Where this comes from

Reported directly by XOMA Corporation in its filing.

Tagged under the XBRL concept us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss.

The official record: XOMA Corporation’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about XOMA Corporation's net gains (losses) on investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is XOMA Corporation's net gains (losses) on investments?
XOMA Corporation (XOMA) reported net gains (losses) on investments of $112K in Q1 2026.
How has XOMA Corporation's net gains (losses) on investments changed year-over-year?
XOMA Corporation's net gains (losses) on investments increased by 109.8% year-over-year, from -$1.15M to $112K.
What is the long-term trend for XOMA Corporation's net gains (losses) on investments?
Over 2 years (2021 to 2023), XOMA Corporation's net gains (losses) on investments has grown at a -55.4% compound annual growth rate (CAGR), from -$919K to -$183K.
What does net gains (losses) on investments mean?
Realized and unrealized gains/losses on investments removed from operating cash flow since they're investing-related.